Please read and agree to the terms and conditions of this site.
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com 3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@slashgear.com 4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com 4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com 5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@extremetech.com 5 years ago
23andMe, GlaxoSmithKline Will Use Your DNA to Develop New Drugs
@techcrunch.com 7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons
@extremetech.com 7 years ago
Crowdsourced genetics study ferrets out the hereditary roots of depression
@theverge.com 8 years ago
Ancestry.com is talking to the FDA about using DNA to estimate people's risk of disease